NEW YORK, May 5, 2017 /PRNewswire/ -- Juan Monteverde, founder and managing partner atMonteverde & Associates PC, a boutique securities firm headquartered at the Empire State Building in New York City, is investigating OncoGenex Pharmaceuticals, Inc. ("OncoGenex" or the "Company")( NASDAQ:OGXI) and its Board of Directors for potential federal law violations and/or breaches of fiduciary duties in connection the acquisition of Achieve Life Science, Inc. (the "Merger").
The investigation focuses on whether OncoGenex and/or its Board of Directors violated federal securities laws and/or breached their fiduciary duties to the Company's stockholders by 1) failing to properly value the Merger and 2) failing to disclose all material information in connection with the Merger.
Click here for more information:www.monteverdelaw.com/investigations. It is free and there is no cost or obligation to you
Gar nicht mal so gut :-(